• On 19 May 2026, Arteris, Inc. announced that its FlexNoC 5 interconnect IP and Magillem integration software power Li Auto’s proprietary 5 nm SoCs in the new L9 Livis smart SUV, supporting AI compute data movement and stringent functional safety needs across diverse on-chip processors.
• This deployment underscores how Arteris’ system IP is being used at the core of advanced automotive AI platforms, potentially reinforcing its role in complex, safety-critical vehicle electronics architectures.
• Next, we’ll examine how this Li Auto SoC deployment may influence Arteris’ investment narrative, particularly around AI-driven automotive demand.

Find 51 companies with promising cash flow potential yet trading below their fair value.

Arteris Investment Narrative Recap

To own Arteris, you need to believe its system IP becomes embedded at the heart of increasingly complex AI and automotive chips, eventually supporting a path toward improved economics despite current losses. The Li Auto 5 nm SoC win reinforces the AI automotive catalyst by placing Arteris inside a high-profile smart SUV platform, but it does not fundamentally change the key near term risk that rising costs and ongoing net losses could weigh on the business if deal flow slows.

Among recent announcements, the Q1 2026 earnings and updated full year guidance matter most here. Management reported revenue of US$22.94 million and maintained an outlook of US$91.0 million to US$95.0 million for 2026, which frames how wins like Li Auto might feed into the top line. At the same time, Arteris remained loss making, with a Q1 net loss of US$7.96 million, keeping the profitability timeline central to the investment debate.

Yet beneath these growth headlines, investors should also be aware that...

Arteris' narrative projects $130.9 million revenue and $15.0 million earnings by 2029.

Uncover how Arteris' forecasts yield a $20.50 fair value, a 41% downside to its current price.

Exploring Other Perspectives

Some analysts were already very optimistic, projecting about 24.5% annual revenue growth to roughly US$136.2 million by 2029, but Li Auto’s deployment and ongoing customer concentration risk could both shift how you view that upbeat scenario.

Explore 5 other fair value estimates on Arteris - why the stock might be worth less than half the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Arteris research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Arteris research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arteris' overall financial health at a glance.

Ready For A Different Approach?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.
• Uncover the next big thing with 27 elite penny stocks that balance risk and reward.
• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.